Marama Parore
He Rongoā Pai, He Oranga Whanau is a two day education programme that aims to increase the awareness and understanding of the appropriate use, storage and disposal of medicines within the Māori community. This is a pilot programme that has been initiated by PHARMAC in an effort to ensure Māori have access to quality information regarding the access and optimal use of subsidised pharmaceuticals, and the implications they have on cultural aspects of Maori Health.
There are several key themes and concepts relating to how Māori use medicines. The objective of this programme is to support Maori Health Workers to develop key strategies that encourage whanau to safely and effectively use medication and rongoā, and how both are positive investments in their health.
Key Themes and Concepts explored in the programme include:
• The State of Maori Health Today;
• The Role of Pharmaceuticals in New Zealand Health;
• Rongoā Māori;
• Interactions / adverse effects of pharmaceuticals and rongoā;
• Treatment of and effective communication with whanau;
• Disease states and how these impact on whanau;
• Enhancing communication skills when dealing with primary health providers that empower whanau to be in control of their own health care.
Marama Parore - Manager Maori Health - Manager Demand Side (Acting)
Marama Parore (Ngati Whatua, Ngati Kahu, Nga Puhi) Maori Health Manager at government drug-funding agency PHARMAC since December 2004 and Acting Manager Demand Side team since July 2005.
The creation of the Maori Health Manager position was one of the results from PHARMAC’s Maori Responsiveness Strategy, which was launched in September 2002. The Strategy has six key aims, including improving Maori representation within PHARMAC, improving how PHARMAC responds to Maori health needs, and improving information on medicines for Maori.
Since her appointment, Marama has played a lead role in the development of a new visual aid for asthma educators, and is also managing the wider roll-out of a project to encourage awareness of cardiovascular risk. Respiratory illnesses (such as asthma) and cardiovascular health are key Maori health issues and were identified as such during consultation on PHARMAC’s Maori Responsiveness Strategy.
Marama has a background in community nursing, teaching, training and management. She has worked for the Public Health Commission, Plunket, the Central Regional Health Authority, and as a self-employed consultant.
Marama also held a position within the Health Funding Authority as a national project manager overseeing asthma strategy development and she was a key member of the national diabetes strategy.
Marama has 4 children and 5 mokopuna.
Wise Use of Antibiotics 2007
08-August-2007
The Wise use of Antibiotics is in its tenth year. It aims to raise...
Launch of the Wise Use of Antibiotics campaign
10-August-2006
Do you need pills for winter ills?
With cold and flu season upon...
One Heart Many Lives campaign up and running in the Hawke's Bay
02-June-2006
The PHARMAC team are working together with Hawke's Bay DHB and a ra...
Conference DVD available now
22-November-2005
The 2005 WCMAD Conference DVD is available in two versions. The edited...
Antibiotic resistance still growing
10-October-2005
Some bacteria are becoming resistant to a number of antibiotics at a...
PHARMAC and Social Marketing
10-October-2005
PHARMAC uses social marketing techniques in the development and...